SCHEMBL20858441

SCHEMBL20858441

Cc1ccc2oc3cc(-c4ccc5c(sc6ccccc65)c4C)ccc3c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.41
ALOX5 P09917 1/20 0.39
MAOB P27338 2/20 0.35
MAPT P10636 6/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ESR2 Q92731 1/20 0.34
TNKS O95271 2/20 0.33
TNKS2 Q9H2K2 2/20 0.33
PARP1 P09874 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
MAOA P21397 1/20 0.33
AHR P35869 2/20 0.32
MEN1 O00255 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17319278 0.83 ALOX5 (0.54) PRKDCALOX5MAOBMAPTKDM4E
SCHEMBL19731980 0.82 ALOX5 (0.43) PRKDCALOX5MAPTKDM4EALDH1A1
SCHEMBL19402417 0.81 PRKDC (0.43) PRKDCALOX5MAPTALDH1A1ESR2
SCHEMBL24161282 0.81 ALOX5 (0.45) PRKDCALOX5MAPTKDM4EALDH1A1
SCHEMBL22725234 0.80 MAOB (0.43) MAOBMAPTKDM4EALDH1A1HPGD
SCHEMBL20156868 0.79 MAOB (0.45) PRKDCALOX5MAOBMAPTKDM4E
SCHEMBL20706911 0.77 ALOX5 (0.59) PRKDCALOX5MAPTKDM4EALDH1A1
SCHEMBL24279234 0.76 PRKDC (0.36) PRKDCALOX5MAOBTNKSTNKS2
SCHEMBL26254507 0.75 ALOX5 (0.51) PRKDCALOX5KDM4ETNKSMAOA
SCHEMBL20095281 0.75 MAOB (0.39) ALOX5MAOBMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-23 US disclosed
US-20190131547-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS UDC IRELAND LTD (IE) 2019-05-02 US disclosed
US-10249827-B2 Azadibenzofurans for electronic applications UDC IRELAND LIMITED (IE) 2019-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ETV6, ESR1 PRKDC 3506/4885ALOX5 2172/4885MAOB 1358/4885
US-20190131547-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS AZI2, BRPF1, CCNB1 PRKDC 4036/4885ALOX5 1148/4885MAOB 122/4885
US-10249827-B2 Azadibenzofurans for electronic applications AZI2, BRPF1, CCNB1 PRKDC 4036/4885ALOX5 1148/4885MAOB 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.